Literature DB >> 24136474

Wogonin influences vascular permeability via Wnt/β-catenin pathway.

Xiuming Song1, Yuxin Zhou1, Mi Zhou1, Yujie Huang1, Zhiyu Li1, Qidong You1, Na Lu1, Qinglong Guo1.   

Abstract

Wogonin, a flavone from the root of Scutellaria baicalensis Georgi, has shown various biological activities. In our previous study, it was confirmed that wogonin could decrease the expression of hypoxia-inducible factor-1α (HIF-1α) by affecting its stability under hypoxia. However, it is still unknown whether wogonin could influence Wnt/β-catenin pathway under hypoxia. In this study, we found that wogonin disrupted Wnt/β-catenin signaling and reduced the secretion of vascular endothelial growth factor (VEGF, also known as vascular permeability factor, VPF), which increased vascular permeability in certain diseases. It was found that wogonin suppressed HUVECs hyperactivity and actin remodeling induced by hypoxia, inhibited transendothelial cell migration of the human breast carcinoma cell MDA-MB-231 and the extravasated Evans in vivo Miles vascular permeability assay. Wogonin-treated cells showed a decrease in the expression of Wnt protein and its co-receptors, as well as a parallel increase in the expression of Axin and GSK-3β in degradation complex, leading to degradation of β-catenin. In addition, wogonin promoted the binding between Axin and β-catenin, increased ubiquitination of β-catenin and promoted its degradation. Interestingly, wogonin decreased the expression of TCF-1, TCF-3, and LEF-1 and inhibited nuclear accumulation of β-catenin as well as the binding of β-catenin and TCF-1, TCF-3, or LEF-1. All of the above results showed that wogonin could inhibit the expression of VEGF, which is an important factor regulated by β-catenin. Taken together, the results suggested that wogonin was a potent inhibitor of Wnt/β-catenin and influenced vascular permeability, and this might provide new therapeutics in certain diseases.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Wnt/β-catenin; degradation; vascular permeability; wogonin

Mesh:

Substances:

Year:  2013        PMID: 24136474     DOI: 10.1002/mc.22093

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  3 in total

1.  Wogonoside Attenuates Cutaneous Squamous Cell Carcinoma by Reducing Epithelial-Mesenchymal Transition/Invasion and Cancer Stem-Like Cell Property.

Authors:  Xiuyong Wang; Yuan Chang; Ming Gao; Fan Zhang
Journal:  Onco Targets Ther       Date:  2020-10-09       Impact factor: 4.147

2.  Could an endoneurial endothelial crosstalk between Wnt/β-catenin and Sonic Hedgehog pathways underlie the early disruption of the infra-orbital blood-nerve barrier following chronic constriction injury?

Authors:  Nathan Moreau; Annie Mauborgne; Pierre-Olivier Couraud; Ignacio A Romero; Babette B Weksler; Luis Villanueva; Michel Pohl; Yves Boucher
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

3.  Therapy Effects of Wogonin on Ovarian Cancer Cells.

Authors:  Jiang Ruibin; Jin Bo; Wan Danying; Zhu Chihong; Feng Jianguo; Gu Linhui
Journal:  Biomed Res Int       Date:  2017-10-18       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.